Equity Research, Broker Reports, and media content on Dechra Pharmaceuticals PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Dechra Pharmaceuticals PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Dechra Pharmaceuticals PLC

Company Profile

  • Personnel
  • Ian Page, CEO
  • Tony Rice, Chairman

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Dechra Pharmaceuticals PLC. We currently have 236 research reports from 7 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 3236/5525p
  • Daily Volume: N/A
  • Daily Liquidity: (0.19%)
  • # Shares: 108.4m
  • Market Cap: £4,540m
  • Latest PE (hist): 94.69
  • Div Yield: 0.83
Date Source Announcement
13Jan22 07:00 RNS Dechra Pharmaceutcls - Trading Update and Notice of Half Year Results
11Jan22 07:00 RNS Dechra Pharmaceutcls - Dechra acquires worldwide rights to verdinexor
31Dec21 07:29 RNS Dechra Pharmaceutcls - Total Voting Rights
20Dec21 15:20 RNS Dechra Pharmaceutcls - Holding(s) in Company
30Nov21 12:17 RNS Dechra Pharmaceutcls - Total Voting Rights
24Nov21 08:19 RNS Dechra Pharmaceutcls - Holding(s) in Company
19Nov21 07:00 RNS Dechra Pharmaceutcls - Directorate Change
  • Frequency of research reports

     

  • Research reports on

    Dechra Pharmaceuticals PLC

  • Providers covering

    Dechra Pharmaceuticals PLC